The Runx genes: lineage-specific oncogenes and tumor suppressors
- PMID: 15156187
- DOI: 10.1038/sj.onc.1207130
The Runx genes: lineage-specific oncogenes and tumor suppressors
Abstract
The Runx genes present a challenge to the simple binary classification of cancer genes as oncogenes or tumor suppressors. There is evidence that loss of function of two of the three mammalian Runx genes promotes cancer, but in a highly lineage-restricted manner. In human leukemias, the RUNX1 gene is involved in various chromosomal translocation events that create oncogenic fusion proteins, at least some of which appear to function as dominant-negative inhibitors of the normal gene product. Paradoxically, evidence is mounting that structurally intact Runx genes are also oncogenic when overexpressed. All the three murine genes act as targets for transcriptional activation by retroviral insertional mutagenesis, and the oncogenic potential of Runx2 has been confirmed in transgenic mice. Moreover, the RUNX1 gene is often amplified or overexpressed in cases of acute leukemia. The state of progress in elucidating the oncogenic roles of the Runx genes is the subject of this review, and we draw together recent observations in a tentative model for the effects of Runx deregulation on hematopoietic cell differentiation. We suggest that lineage-specific factors determine the sensitivity to the oncogenic effects of loss or overexpression of Runx factors.
Similar articles
-
Oncogenic potential of the RUNX gene family: 'overview'.Oncogene. 2004 May 24;23(24):4198-208. doi: 10.1038/sj.onc.1207755. Oncogene. 2004. PMID: 15156173 Review.
-
Role of RUNX family members in transcriptional repression and gene silencing.Oncogene. 2004 May 24;23(24):4220-4. doi: 10.1038/sj.onc.1207122. Oncogene. 2004. PMID: 15156176 Review.
-
Structure and regulated expression of mammalian RUNX genes.Oncogene. 2004 May 24;23(24):4211-9. doi: 10.1038/sj.onc.1207670. Oncogene. 2004. PMID: 15156175 Review.
-
Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.Cancer Res. 2002 Dec 15;62(24):7181-5. Cancer Res. 2002. PMID: 12499254
-
Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins.Oncogene. 2004 May 24;23(24):4232-7. doi: 10.1038/sj.onc.1207131. Oncogene. 2004. PMID: 15156178 Review.
Cited by
-
Sequence analysis of mutations and translocations across breast cancer subtypes.Nature. 2012 Jun 20;486(7403):405-9. doi: 10.1038/nature11154. Nature. 2012. PMID: 22722202 Free PMC article.
-
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.Immunol Res. 2013 May;56(1):109-21. doi: 10.1007/s12026-012-8381-8. Immunol Res. 2013. PMID: 23247987 Review.
-
Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.Front Oncol. 2019 Feb 21;9:48. doi: 10.3389/fonc.2019.00048. eCollection 2019. Front Oncol. 2019. PMID: 30847297 Free PMC article. Review.
-
Role of the RUNX1-EVI1 fusion gene in leukemogenesis.Cancer Sci. 2008 Oct;99(10):1878-83. doi: 10.1111/j.1349-7006.2008.00956.x. Cancer Sci. 2008. PMID: 19016745 Free PMC article. Review.
-
Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers.Oncogene. 2016 Mar 17;35(11):1386-98. doi: 10.1038/onc.2015.196. Epub 2015 Jun 15. Oncogene. 2016. PMID: 26073086 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources